Source link : https://newshealth.biz/health-news/add-on-nivolumab-extends-dfs-in-locally-advanced-head-and-neck-cancer/
(MedPage Today) — CHICAGO – The postoperative addition of nivolumab (Opdivo) to chemoradiotherapy (CRT) extended disease-free survival (DFS) in certain patients with locally advanced head and neck squamous cell carcinoma (HNSCC), according… Source link : https://www.medpagetoday.com/meetingcoverage/asco/115840 Author : Publish date : 2025-06-01 21:35:00 Copyright for syndicated content belongs to the linked Source.
The post Add-On Nivolumab Extends DFS in Locally Advanced Head and Neck Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-01 21:35:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8